// App-Quantinova.ai

2076 : Novel Flow Cytometry-Based Biomarkers Predict Recurrence in Myeloma Patients through Detection of MRD in the Bone Marrow and CTCs in Peripheral Blood

Researchers

Presenter

  • Barbara Muz

Principal Investigators

  • Pilar De La Puente

  • Justin A King

  • Daniel R Kohnen

  • Ravi Vij

  • Abdel Kareem Azab

Medical Centers

  • Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO.

  • Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 14

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 38

  • Fc gamma RIIIa

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved